BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33588611)

  • 1. Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study.
    Kearney J; Drozd M; Walker AM; Slater TA; Straw S; Gierula J; Paton M; Lowry J; Cole C; Witte KK; Cubbon RM; Kearney MT
    Diab Vasc Dis Res; 2021; 18(1):1479164120984433. PubMed ID: 33588611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk.
    Böhm M; Schumacher H; Werner C; Teo KK; Lonn EM; Mahfoud F; Speer T; Mancia G; Redon J; Schmieder RE; Sliwa K; Marx N; Weber MA; Laufs U; Williams B; Yusuf S; Mann JFE
    Cardiovasc Diabetol; 2022 Jan; 21(1):12. PubMed ID: 35057807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    He J; Shlipak M; Anderson A; Roy JA; Feldman HI; Kallem RR; Kanthety R; Kusek JW; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Wolf M; Zhang X; Raj D; Hamm L;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident heart failure and the subsequent risk of progression to end stage kidney disease in individuals with type 2 diabetes.
    Liu S; Liu JJ; Ang K; Lee J; Chan C; Gurung RL; Zheng H; Tang J; Lim SC
    Cardiovasc Diabetol; 2024 Jun; 23(1):204. PubMed ID: 38879473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between mortality and speed of eGFR decline in the 3 months prior to dialysis initiation.
    Inaguma D; Murata M; Tanaka A; Shinjo H
    Clin Exp Nephrol; 2017 Feb; 21(1):159-168. PubMed ID: 27084516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up: Clinical Profiling and Mortality.
    Zamora E; Codina P; Aimo A; Lupón J; Domingo M; Troya M; Santiago-Vacas E; Cediel G; Borrellas A; Ruiz-Cueto M; Romero-González GA; Santesmases J; Nuñez J; Bover J; Ara J; Bayes-Genis A
    JACC Heart Fail; 2024 May; 12(5):849-859. PubMed ID: 38430086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
    Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
    Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated Glomerular Filtration Rate at Transplant Listing and Other Predictors of Post-Heart Transplant Mortality and the Development of ESRD.
    Kumar A; Howard A; Thomas CP
    Transplantation; 2020 Nov; 104(11):2444-2452. PubMed ID: 32028343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and higher HbA1c levels are independently associated with adverse renal outcomes in inpatients following multiple hospital admissions.
    Torkamani N; Churilov L; Robbins R; Jerums G; Beik V; Radcliffe N; Patterson S; Bellomo R; Burns J; Hart GK; Lam Q; Power DA; MacIsaac RJ; Johnson DF; Zajac J; Ekinci EI
    J Diabetes Complications; 2020 Jan; 34(1):107465. PubMed ID: 31735639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.